EVEX earnings analysis
What we found in EVEX's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Eve remained pre-revenue in Q2 2026, but reduced its net loss to $34.2 million from $64.7 million a year earlier as R&D expense fell by $16.7 million, including favorable contractor cost-estimate adjustments. The improvement in earnings was counterbalanced by a $115.3 million first-half operating cash outflow, up $34.8 million year over year, and a 119% increase in quarterly interest expense to $5.2 million. Management cited approximately $531.3 million of liquidity as sufficient for at least 12 months and continues to anticipate commercial operations beginning in 2028; no explicit financial guidance was provided.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Net loss narrowed 47% year over year
- Eve remained pre-revenue, reporting $0 revenue, but its Q2 net loss narrowed 47% year over year to $34.2 million from $64.7 million. Operating loss improved to $37.2 million from $53.9 million.
- R&D expense fell $16.7 million
- R&D expense declined $16.7 million year over year to $28.9 million, primarily from favorable revisions to previously recorded contractor cost estimates. Management said Embraer MSA activity nevertheless increased for the eVTOL program, customer services and CapEx-related work.
- Liquidity totaled $531.3 million
- Liquidity totaled approximately $531.3 million at June 30, consisting of $60.8 million of cash, cash equivalents and restricted cash, $342.5 million of financial investments, $117.7 million of undrawn debt capacity and $10.2 million of grant commitments.
- Prototype testing and order-interest progress
- The company completed its 50th uncrewed full-scale eVTOL prototype test flight in April 2026 and continues to anticipate commercialization beginning in 2028. Eve also reported approximately 2,700 non-binding eVTOL letters of intent.
- Investment income increased to $4.7 million
- Financial investment income rose to $4.7 million from $3.5 million in Q2 2025, partly offsetting operating costs as the company held a higher average investment balance.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Operating cash burn worsened $34.8 million
- Cash consumption intensified: operating cash outflow was $115.3 million for the first six months of 2026, worsening by $34.8 million from $80.5 million in the prior-year period. The company continues to expect negative operating cash flow until sustainable commercial operations begin.
- No revenue before anticipated 2028 launch
- Eve has generated $0 revenue to date and anticipates commercialization only beginning in 2028. It therefore expects to require substantial additional capital while funding engineering, certification, manufacturing and commercialization.
- Higher debt expense and rate exposure
- Financing costs and rate sensitivity increased: Q2 interest expense rose 119% year over year to $5.2 million, while $162.4 million, or 52%, of long-term debt was variable-rate at June 30, 2026. A 100-basis-point rate change would affect annual interest expense by about $1.6 million.
- No material risk-factor update; certification remains key
- The filing states there were no material changes to risk factors from the 2025 Form 10-K. However, execution remains dependent on obtaining certification from ANAC, the FAA and EASA and meeting the planned 2028 commercialization timetable.
What they said about what is next.
No numeric revenue or EPS guidance was provided in the 10-Q. Management anticipates beginning commercialization of its eVTOL and services-and-support business in 2028 and expects approximately $531.3 million of total liquidity to fund the operating plan for at least the next 12 months.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 5, 2026
- Eve Holding, Inc. delivered disappointing results in its latest 10-Q filing for the quarter ending March 31, 2026. The company reported no revenue, consistent with prior periods, and a net loss of $68.8 million, marking…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing EVEX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever